Multiple Sclerosis Flashcards
Multiple Sclerosis: features
visual compromise
stiffness
weakness
Multiple Sclerosis: pathology
autoimmune disease marked by chronic inflammation of the CNS
mononuclear cells infiltrate the perivascular space –> demyelinate and destroy axons –> formation of plaques due to changes in the glial cells
What is the key to diagnosis of multiple sclerosis?
dissemination of plaques in time and space
What are the 4 types of multiple sclerosis?
relapsing remitting MS (target of therapy)
primary progressive MS
secondary progressive MS
progressive relapsing MS (primary progressive w/ activity)
What are the 3 categories of treatment of multiple sclerosis?
Tx of exacerbation (corticosteroids)
disease modifying therapies
symptomatic therapies (spasticity, bladder sx, sensory sx, fatigue)
What virus status needs to be checked when deciding on treatment for multiple sclerosis?
John Cunningham virus
Disease Modifying Therapy: goals
reduce annual relapse rate lessen severity of relapses slow progression of changes on MRI slow progression of disability slow cognitive decline reduce second attack after CIS
Disease Modifying Therapy: First Generation
dec relapse rate
dec formation of new white matter lesion
takes 1-2 yrs to be efficacious
interferon
glatiramer acetate
DMT: Avonex
relapsing MS
interferon (alpha)
low potency
DMT: Rebif
relapsing MS
interferon (alpha)
high potency
DMT: Betaseron, Extavia
relapsing MS
interferon (beta)
high potency
pregnancy category C
DMT: Plegridy
RRMS
pegylated interferon (alpha) (long acting)
pregnancy category C
premedicate/concurrent use w/ antipyretic/analgesic for flu like sx
DMT: copaxone glatopa
CIS, RRMS
glatiramer acetate
pregnancy category B
DMT: Interfeon: ADEs
depression
flu like symptoms
leukopenia
injection site reaction
DMT: glatiramer acetate: ADEs
injection site reaction infection hypersensitivity chest tightness urticaria
Disease Modifying Therapy: Second Generation
Natalizumab Mitoxantrone Fingolimod Teriflunomide Dimethyl fumarate Alemtuzumab Ocrelizumab
DMT: Fingolimod
oral
relapsing MS
pregnancy category C
ADE: lymphocytopenia, macular retinal edema, AV block, infection, headache
sequesters lymphocytes
reduces infiltration of T lymphocytes and macrophages into CNS
neuroprotective
DMT: Teriflunomide
oral
relapsing MS
pregnancy category X
ADE: Steven–Johnson syndrome, liver failure, neutropenia, respiratory infection, activation of TB, alopecia, neuropathy
DMT: Dimethyl Fumarate
oral
relapsing MS
pregnancy category C
ADE: flushing, rash, pruritus, GI discomfort, lymphocytopenia, increased LFTs, albuminuria
DMT: Natalizumab
IV
relapsing MS
pregnancy category C
ADE: PML, depression, fatigue, respiratory infx, arthralgia, hepatotoxicity
activated lymphocytes denied entry past BBB
DMT: Alemtuzumab
IV
RRMS
premedicate w/ high dose corticosteroid
administer herpes viral prophylaxis
pregnancy category C
ADE: Infusion reactions, infections (nasophyaryngitis, UTI, URI, herpes viral infections), autoimmune disorders, thyroid disorders, immune-mediated thrombocytopenic purpura, Goodpasture syndrome
depletes T cells, B cells, NK cells, monocytes
DMT: Ocrelizumab
IV
relapsing or progressive MS
premedicate w/ methylprednisolone
ADE: Infusion reactions, infections (nasophyaryngitis, UTI, URI, herpes viral infections; skin infections; neutropenia
B cell depletion